L088-1428 Screening compound: N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

L088-1428 Screening compound: N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide
L088-1428 Screening compound: N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L088-1428
N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L088-1428

Molecular Formula

C22H26BrN3O5 (C22 H26 BrN3 O5)

Compound Name

N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-3,4,5-trimethoxybenzamide

IUPAC name

N-[(E)-N'-(3-bromophenyl)-N-[(oxolan-2-yl)methyl]carbamimidoyl]-345-trimethoxybenzamide

SMILES

COc1cc(C(N/C(/NCC2OCCC2)=N/c2cccc(Br)c2)=O)cc(OC)c1OC

InChI

InChI=1S/C22H26BrN3O5/c1-28-18-10-14(11-19(29-2)20(18)30-3)21(27)26-22(24-13-17-8-5-9-31-17)25-16-7-4-6-15(23)12-16/h4,6-7,10-12,17H,5,8-9,13H2,1-3H3,(H2,24,25,26,27)/t17-/m1/s1

InChI Key

AXCYUGFBCZKRJH-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27231178

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.37

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.467

Distribution Coefficient, logD

3.460

Water Solubility, LogSw

-3.67

Polar Surface Area

73.484

Acid Dissociation Constant (pKa)

11.32

Base Dissociation Constant (pKb)

5.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.40

L088-1428 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L088-1428 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L088-1428?
Check Price and Availability of L088-1428, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L088-1428 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L088-1428
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L088-1428
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L088-1428 available by request